ID   HepaRG 5F
AC   CVCL_B6A6
SY   HepaRG 5F Control Cells
DR   Wikidata; Q111733354
RX   PubMed=27713827;
WW   https://www.sigmaaldrich.com/catalog/product/sigma/mtox1010
CC   Characteristics: These cells were modified with the use of transfected mRNA encoding ZFNs targeting a specific site (Sigma-Aldrich).
CC   Derived from site: In situ; Liver; UBERON=UBERON_0002107.
DI   NCIt; C3098; Hepatitis C infection
DI   NCIt; C3099; Hepatocellular carcinoma
DI   ORDO; Orphanet_88673; Hepatocellular carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_9720 ! HepaRG
SX   Female
AG   Age unspecified
CA   Cancer cell line
DT   Created: 17-03-22; Last updated: 29-06-23; Version: 5
//
RX   PubMed=27713827; DOI=10.1002/prp2.264;
RA   Williamson B., Lorbeer M., Mitchell M.D., Brayman T.G., Riley R.J.;
RT   "Evaluation of a novel PXR-knockout in HepaRG(TM) cells.";
RL   Pharmacol. Res. Perspect. 4:e00264.1-e00264.11(2016).
//